BPF-001

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameBPF-001

Drug Alias Nameautologous mesenchymal stromal cells (Videregen)autologous mesenchymal stem cells on decellularized tracheal scaffold (Videregen)BPF-001

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsFistulaRespiratory Tract Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVideregen Ltd

China Registration ClassN/A

Develop Information

Active CompaniesVideregen Ltd

Inactive CompaniesN/A

Active IndicationsRespiratory Tract Diseases

Inactive IndicationsFistula

Other Information

ATC CodeN/A